Cargando…
Pirfenidone suppresses polarization to M2 phenotype macrophages and the fibrogenic activity of rat lung fibroblasts
Pirfenidone is a representative medication to treat interstitial pulmonary fibrosis. Researchers reported pirfenidone (>100 µg/ml) significantly suppressed fibroblast growth in vitro. However, clinically, the maximum concentration of pirfenidone in the blood is approximately 10 µg/ml. We hypothes...
Autores principales: | Toda, Michihito, Mizuguchi, Shinjiro, Minamiyama, Yukiko, Yamamoto-Oka, Hiroko, Aota, Takanori, Kubo, Shoji, Nishiyama, Noritoshi, Shibata, Toshihiko, Takemura, Shigekazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064814/ https://www.ncbi.nlm.nih.gov/pubmed/30087545 http://dx.doi.org/10.3164/jcbn.17-111 |
Ejemplares similares
-
Acute exacerbation of idiopathic pulmonary fibrosis model by small amount of lipopolysaccharide in rats
por: Miyamoto, Hikaru, et al.
Publicado: (2022) -
Attenuation of Bleomycin-Induced Pulmonary Fibrosis in Rats with S-Allyl Cysteine
por: Tsukioka, Takuma, et al.
Publicado: (2017) -
Therapeutic administration of an ingredient of aged-garlic extracts, S-allyl cysteine resolves liver fibrosis established by carbon tetrachloride in rats
por: Kodai, Shintaro, et al.
Publicado: (2015) -
Long‐term outcomes after biliary diversion operation for pancreaticobiliary maljunction in adult patients
por: Aota, Takanori, et al.
Publicado: (2019) -
S-Allyl cysteine improves nonalcoholic fatty liver disease in type 2 diabetes Otsuka Long-Evans Tokushima Fatty rats via regulation of hepatic lipogenesis and glucose metabolism
por: Takemura, Shigekazu, et al.
Publicado: (2013)